Loading clinical trials...
Loading clinical trials...
People living with obesity have a higher risk of late-life cognitive decline and developing dementia. In women, the risk of cognitive decline may further raise during the menopausal transition, a peri...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Max Planck Institute for Human Cognitive and Brain Sciences
NCT07508241 · Obesity, Overweight and/or Obesity, and more
NCT07237750 · Overweight and/or Obesity, Metabolic Syndrome, and more
NCT07243171 · Overweight and/or Obesity, Weight Management
NCT07022925 · Perimenopause, Perimenopausal Depression, and more
NCT07395466 · Overweight , Obesity, Overweight or Obese Adults, and more
Max Planck Institute for Human Cognitive and Brain Sciences
Leipzig, Saxony
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions